Search

Your search keyword '"Ketter, Ralf"' showing total 351 results

Search Constraints

Start Over You searched for: Author "Ketter, Ralf" Remove constraint Author: "Ketter, Ralf"
351 results on '"Ketter, Ralf"'

Search Results

5. Clear cell meningiomas are defined by a highly distinct DNA methylation profile and mutations in SMARCE1

7. N2M2/NOA-20: Phase I/IIa umbrella trial of molecularly matched targeted therapies plus radiotherapy in patients with newly diagnosed glioblastoma without MGMT promoter hypermethylation.

9. DNA methylation-based classification of central nervous system tumours.

12. CDKN2A/B homozygous deletion is associated with early recurrence in meningiomas

15. The intra-tumoral heterogeneity in glioblastoma — a limitation for prognostic value of epigenetic markers?

16. Mutational patterns and regulatory networks in epigenetic subgroups of meningioma

18. Chordoid meningiomas can be sub-stratified into prognostically distinct DNA methylation classes and are enriched for heterozygous deletions of chromosomal arm 2p

19. DNA methylation-based classification and grading system for meningioma: a multicentre, retrospective analysis

21. Supplementary Figure Legends from Cytotoxic T Cells and their Activation Status are Independent Prognostic Markers in Meningiomas

22. Supplementary Tables 1-2 from Cytotoxic T Cells and their Activation Status are Independent Prognostic Markers in Meningiomas

23. Supplementary Figure 1 from MGMT Promoter Methylation Is a Strong Prognostic Biomarker for Benefit from Dose-Intensified Temozolomide Rechallenge in Progressive Glioblastoma: The DIRECTOR Trial

24. Supplementary Tables 1-7 from MGMT Promoter Methylation Is a Strong Prognostic Biomarker for Benefit from Dose-Intensified Temozolomide Rechallenge in Progressive Glioblastoma: The DIRECTOR Trial

25. Supplementary Figures 1-5 from Cytotoxic T Cells and their Activation Status are Independent Prognostic Markers in Meningiomas

26. Data from Cytotoxic T Cells and their Activation Status are Independent Prognostic Markers in Meningiomas

35. Surviving a Self-inflicted Transorbital Pen Intrusion to the Cerebellum: Case Report.

36. TERT Promoter Mutations and Risk of Recurrence in Meningioma

37. Temozolomide chemotherapy alone versus radiotherapy alone for malignant astrocytoma in the elderly: the NOA-08 randomised, phase 3 trial

40. PATH-39. INTEGRATED MOLECULAR-MORPHOLOGICAL MENINGIOMA CLASSIFICATION: A MULTICENTER RETROSPECTIVE ANALYSIS, RETRO- AND PROSPECTIVELY VALIDATED

41. AKT1E17K mutations cluster with meningothelial and transitional meningiomas and can be detected by SFRP1 immunohistochemistry

43. Secretory meningiomas are defined by combined KLF4 K409Q and TRAF7 mutations

50. Ultrasonic Radio-Frequency Spectrum Analysis Differentiates Normal and Edematous Brain Tissue from Meningioma Intraoperatively

Catalog

Books, media, physical & digital resources